from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1333/-

LFCtreatmentdescriptionclass of inhibitor

-1.272

Amikacinug/mL Amikacintranslation

-1.754

Cap5-10ug/mL Capreomycintranslation

-2.056

Rox10-50 ug/mL Roxithromycintranslation

-0.651

SM2-5 ug/mL Streptomycintranslation

-1.740

Tet5-10 ug/mL Tetracyclinetranslation

-0.218

Rif0.2-5ug/mL Rifampicintranscription

-0.365

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.551

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.216

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.948

CPZ10-50 ug/mL Chlorpromazinerespiration

0.983

Clofazimine10-13 ug/mL Clofaziminerespiration

0.013

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.838

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.039

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.104

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.255

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.480

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.291

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.341

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.157

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.812

KCN5-20 ug/mL Potassium cyaniderespiration

0.719

NaN30.2-2 mM Sodium aziderespiration

0.143

Nigericin50 uM Nigericinrespiration

0.192

TRC10-150 ug/mL Triclosanrespiration

1.478

TRZ10-25 ug/mL Thioridazinerespiration

-1.616

Valinomycin0.5-10 uM Valinomycinrespiration

-0.187

ZnSO42 mM ZnSO4respiration

-0.462

menadione6-10 ug/mL Menadionerespiration

0.659

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.109

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.218

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.304

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.507

NRP_1Non-replicating persistence stage 1dosRassociated

0.082

Amp0.2mg/mL AmpicillincellWall

0.168

Cephalexin20-100 ug/mL CephalexincellWall

-0.024

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.240

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.255

EMB10-20 ug/mL EthambutolcellWall

0.447

Eta12-40 ug/mL EthionamidecellWall

0.550

INH0.2-0.4 ug/mL IsoniazidcellWall

0.352

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.435

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.005

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.062

BZA0.12 mg/mL BenzamidearomaticAmides

-1.029

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.244

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.564

H2O24 mM hydrogen peroxideDNAdamaging

-0.145

Levo10 ug/mL LevofloxacinDNAdamaging

-0.460

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.499

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.165

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.648

UVUV-irradiationDNAdamaging

-0.339

ARP41-4 ug/mL Antitubercular compound ARP4?

0.266

Antimycin12.5-50 ug/mL Antimycin A?

-0.244

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.570

PA_110-50 ug/mL Antitubercular compound PA-1?

0.517

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.500

PA8240.2-2 ug/mL PA-824?

1.549

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.795

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.095

Verapamil50 uM Verapamil?

0.069

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.151

methoxatin10-20 ug/mL Methoxatin?